SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report: May 6, 2004 (Date of earliest event reported) BIO-RAD LABORATORIES, INC. ________________________________________________________________ (exact name of registrant as specified in its charter) Commission File: 1-7928 Delaware 94-1381833 ________________________________________________________________ (State or other (I.R.S. Employer jurisdiction of Identification No.) incorporation or organization) 1000 Alfred Nobel Dr. Hercules, California 94547 ________________________________________________________________ (Address of Principal executive offices, including zip code) (510) 724-7000 ________________________________________________________________ (Registrant's telephone number, including area code) ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION. The information in Item 12 of this Report, including Exhibit 99.1 attached hereto, is being furnished pursuant to Item 12 of Form 8-K. Consequently, it is not deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or Securities Act of 1933, as amended, if such subsequent filing specifically references this Form 8-K. On May 6, 2004, Bio-Rad Laboratories, Inc. announced its results of operations and financial condition as of and for the first quarter ended March 31, 2004. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. (c) Exhibits Exhibit Number Description 99.1 Press Release for first quarter financial results of Bio-Rad Laboratories, Inc., dated May 6, 2004. This exhibit is being furnished pursuant to Item 12 of Form 8-K. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-RAD LABORATORIES,INC. Date: May 6, 2004 By: /s/ Christine A. Tsingos Christine A. Tsingos Vice President and Chief Financial Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release for first quarter financial results of Bio-Rad Laboratories, Inc., dated May 6, 2004. This exhibit is being furnished pursuant to Item 12 of Form 8-K.